uniQure Publishes Data Further Demonstrating Favorable Immunogenicity Profile and Broad Utilization of AAV5-Based …NasdaqLEXINGTON, Mass. and AMSTERDAM, the Netherlands, June 15, 2017 (GLOBE NEWSWIRE) — uniQure N.V. (NASDAQ:QURE), a leading gene the… Continue reading
|
IND-Enabling Study Data Published in Human Gene Therapy Clinical Development Support Clinical Development of …
Nasdaq The study, “Safety and Efficacy Evaluation of rAAV2tYF-PR.1-hCNGA3 Vector Delivered by Subretinal Injection in CNGA3 Mutant Achromatopsia Sheep” appears in the June issue of Human Gene Therapy Clinical Development and was led by researchers at … |
STAT |
Q&A: Turning to stem cells to restore vision
STAT In 2014 scientists in Japan launched the world’s first clinical trials using the cells, called induced pluripotent stem cells, and now scientists in the United States are in the run-up to this country’s first trial. iPS cells, as they are known, start … Lab-created antibody could hold the secret to making stem cell therapy saferPhys.Org Is Human Embryonic Stem Cell Research in Jeopardy?Healthline A New Generation of Stem Cell Therapy Launches To The PublicDigital Journal |